Product
Miricorlilant
1 clinical trial
1 indication
Indication
Antipsychotic-induced Weight GainClinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia Taking Antipsychotic Medications (GRATITUDE II)Status: Completed, Estimated PCD: 2023-01-31